Autophagy Activation Induces Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia with FLT3-ITD Mutation

Dan Xu(Wuhan University), Guopan Yu(Nanfang Hospital), Ling Jiang(Nanfang Hospital), Qifa Liu(University of Science and Technology of China), Xuejie Jiang(Nanfang Hospital), Changxin Yin(Nanfang Hospital), Qiang Wang(Beth Israel Deaconess Medical Center), Yishan Chen(Jiangxi University of Science and Technology), Ying Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhao Yin(Nanfang Hospital), Changfen Huang(Nanfang Hospital)
Research Square
July 9, 2021
10.21203/rs.3.rs-676343/v1
Cited by 0

Related Papers

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Prognostic factors and treatment of patients with T‐cell non‐Hodgkin lymphoma
|Cancer|2005|227
Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
|Frontiers in Immunology|2017|209
Non–lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase <i>Ptpn11</i> (Shp2) on malignant transformation of hematopoietic cells
|The Journal of Experimental Medicine|2011|111
Post-translational control of beige fat biogenesis by PRDM16 stabilization
|Nature|2022|109